AstraZeneca reported Phase III results showing tozorakimab reduced COPD exacerbations across patient groups as FDA reviews ...
Waterdrop reported strong second quarter 2026 revenue growth, approved a US$0.03 ADS dividend, and launched a US$50 million ...
Oil prices rose as U.S.-Iran tensions increased supply concerns, with Brent crude reaching $98.25 per barrel and analysts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results